Literature DB >> 20853046

Impact of preoperative breast MRIs on timing of surgery and type of intervention in newly diagnosed breast cancer patients.

Fernando A Angarita1, Sergio A Acuna, Adriana Fonseca, Pavel Crystal, Jaime Escallon.   

Abstract

BACKGROUND: We sought to evaluate the effect of preoperative breast magnetic resonance imaging (BMRI) on the wait time to surgery and to what extent it affects the surgical management plan initially considered.
METHODS: From April 2007 to April 2009, a total of 147 newly diagnosed breast cancer patients who underwent surgery as initial treatment at Marvelle Koffler Breast Centre at Mount Sinai Hospital, Toronto, Ontario, Canada, met the inclusion criteria and were divided into two groups: those who had BMRI (n =71) and those who did not (n = 76). Time to surgery was calculated from the day core biopsy result was available to the date surgery was carried out. Time span between initial surgical consult and the day of the surgery day was also calculated. Change was defined as conversion from conservative to radical surgery and/or unilateral to bilateral procedures.
RESULTS: Overall waiting period between histologic diagnosis and treatment was 34.2 days (BMRI group 36.0 days vs. non-BMRI group 32.3 days, P =0.15); and between date surgical management was propose and date of surgery (BMRI group 24.2 days vs. non-BMRI group 22.5 days, P =0.38). Additional workup resulted in seven otherwise occult malignant lesions that required change. Ten percent of patients who underwent BMRI had change in surgical management. The mastectomy rate was higher among those with preoperative BMRI (initial 12% vs. final 26%, P =0.8), but this was not statistically significant.
CONCLUSIONS: Preoperative BMRI did not delay surgical treatment or correlate with a higher rate of radical treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20853046     DOI: 10.1245/s10434-010-1239-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  7 in total

1.  The Impact of Preoperative Breast Magnetic Resonance Imaging on Surgical Management in Symptomatic Patients With Invasive Lobular Carcinoma.

Authors:  Brian M Moloney; Peter F McAnena; Éanna J Ryan; Ellen O Beirn; Ronan M Waldron; AnnaMarie O Connell; Sinead Walsh; Rachel Ennis; Catherine Glynn; Aoife J Lowery; Peter A McCarthy; Michael J Kerin
Journal:  Breast Cancer (Auckl)       Date:  2020-08-14

2.  Variation in Additional Breast Imaging Orders and Impact on Surgical Wait Times at a Comprehensive Cancer Center.

Authors:  Mehra Golshan; Katya Losk; Melissa A Mallory; Kristen Camuso; Susan Troyan; Nancy U Lin; Sarah Kadish; Craig A Bunnell
Journal:  Ann Surg Oncol       Date:  2015-08-26       Impact factor: 5.344

3.  Implementation of a Breast/Reconstruction Surgery Coordinator to Reduce Preoperative Delays for Patients Undergoing Mastectomy With Immediate Reconstruction.

Authors:  Mehra Golshan; Katya Losk; Melissa A Mallory; Kristen Camuso; Linda Cutone; Stephanie Caterson; Craig A Bunnell
Journal:  J Oncol Pract       Date:  2016-02-16       Impact factor: 3.840

4.  Effect of Magnetic Resonance Imaging on Breast Conservation Therapy versus Mastectomy: A Review of the Literature.

Authors:  Thomas J Painter; Peter J Dipasco; Subhasis Misra; Eli Avisar
Journal:  Int J Surg Oncol       Date:  2011-04-19

5.  The Impact of Pre-Operative Breast MRI on Surgical Waiting Time.

Authors:  Michelle Zhang; Simon Sun; Benoît Mesurolle
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

Review 6.  Viroimmunotherapy of Thoracic Cancers.

Authors:  Alexander S Dash; Manish R Patel
Journal:  Biomedicines       Date:  2017-01-04

7.  Impact of preoperative magnetic resonance imaging on surgery and eligibility for intraoperative radiotherapy in early breast cancer.

Authors:  Wai Yee Chan; Wai Keong Cheah; Marlina Tanty Ramli Hamid; Mohammad Nazri Md Shah; Farhana Fadzli; Shaleen Kaur; Mee Hoong See; Nur Aishah Mohd Taib; Kartini Rahmat
Journal:  PLoS One       Date:  2022-10-18       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.